ANI Pharmaceuticals
ANIP
ANIP
190 hedge funds and large institutions have $664M invested in ANI Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 71 increasing their positions, 64 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
-6
Holders Change %
-3.06%
% of All Funds
4.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
71
Reduced
64
Closed
23
Calls
$4.7M
Puts
$6.33M
Net Calls
-$1.64M
Net Calls Change
-$2.63M
Top Buyers
| 1 |
Goldman Sachs
New York
|
$16.4M |
| 2 |
BlackRock
New York
|
$112M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$30.1M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
$7.03M |
| 5 |
Man Group
London,
United Kingdom
|
$6.19M |
